Priority indications
- Rare diseases
- Neurological disorders
- Immunology
- Oncology
Our Portfolio
Oncology / Immunology
Biologics
Platform
Platform
Incubation
Targeted membrane protein degradation platform for oncology, auto-immune and inflammatory disorders
Neurology
SME
Single asset
Single asset
Incubation
Disease modifier treatment activating the GFRa1/RET complex for the treatment of Parkinson's disease and other indications
Immunology /
Neuro-inflammation
Neuro-inflammation
Biologics
Single asset
Single asset
Incubation
Long-acting neurokine to modulate inflammation in the circulation and in the CNS
Neurology
Gene therapy
Single asset
Single asset
Incubation
Novel and differentiated RNA therapies to address the high unmet need in amyotrophic lateral sclerosis and fronto-temporal dementia
Thesian
Oncology /
Immunology
Immunology
Gene therapy
Platform
Platform
Incubation
Cell specific in-vivo CAR-T approach to treat liquid/solid tumors, as well as autoimmune disorders
Enodia Therapeutics
Neuro-inflammation / Oncology
SME
Platform
Platform
Incubation
Small molecule platform inhibitors able to selectively degrade pathologic secreted and transmembrane proteins
Neurology /
Rare disease
Rare disease
RNA therapeutics
Platform
Platform
Incubation
Modulation of gene expression with a potential for allele-specific targets of interest
Neurology
SME
Single asset
Single asset
Incubation
Neuroplastogen with novel target and mechanism of action able to induce neuroplasticity without psychedelics’ side effects
THerapeutics AREAS FOCUS
Therapeutic Modalities
ANY therapeutic modalities, including SMEs, peptides, biologics, gene & cell therapy...
Platform technologies favored
Key topics of interest
- Novel targets
- Viral and non-viral delivery to CNS, muscle, kidney…
- In vivo cell therapies
- RNA therapeutics
- Synthetic lethality, PARPi resistance
- Protein targeted degradation
- Platform for directed evolution of proteins
- High-throughput phenotypical screens
Not Covered
- Infectious diseases, repurposing
- Standalone diagnostics
- Standalone medical devices
- Standalone software